Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

Laura Botta(Fondazione IRCCS Istituto Nazionale dei Tumori), Stefano Rosso, Margit Mägi(Universidad de Granada), Guido Mazzoleni, Janne Pitkäniemi, Riccardo Capocaccia(Fondazione Progetto Ematologia), Deirdre M. Murray(University College Cork), Nancy Van Damme, Mario Šekerija(London Cancer), Silvia Rossi(University of Parma), Luigino Dal Maso(Centro di Riferimento Oncologico), Keiu Paapsi, Adela Cañete(Universitat de València), Friederike Erdmann(Johannes Gutenberg University Mainz), Paul Walsh, Miklós Garami(Media Working Group), Hans H. Storm(Danish Cancer Society), Alexander Katalinic(Independent Centre for Privacy Protection), Valérie Jooste(Inserm), Alain Monnereau, Claudia Spix(Johannes Gutenberg University Mainz), Eleni Petridou(Senologic Hellenic Society), Rafael Marcos‐Gragera(Generalitat de Catalunya), Ladislav Dušek, Georgios Markozannes, Denisa Krejčí, Emmanuel Désandes(Registre général des cancers de Lille et de sa région), Rocco Galasso, Z. Valerianova(Istituto Superiore di Sanità), Jacqueline Clavel(Cancer Council Queensland), Charles Stiller(Unknown), Claire Poulalhon(Registre général des cancers de Lille et de sa région), Nea Malila(Istituto Superiore di Sanità), Vasos Scoutellas, Kaire Innos(National Institute for Health Development), Ana Mihor(Institute of Oncology Ljubljana), Giuseppe Sampietro, Francesco Cuccaro, Monika Hackl(Universidad de Granada), Claudia Spix(Johannes Gutenberg University Mainz), Fabio Vittadello, Brigitte Lacour(Inserm), E. Van Eycken(Istituto Superiore di Sanità), Helgi Birgisson, Anna Demetriou, Gemma Gatta(Fondazione IRCCS Istituto Nazionale dei Tumori)
The Lancet Oncology
November 15, 2022
Cited by 184


Related Papers